Related Experiment Video
Updated: Jun 20, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Patient level dataset to study the effect of COVID-19 in people with Multiple Sclerosis
Hamza Khan1,2,3,4, Lotte Geys1,2,3, Peer Baneke5
1University MS Center (UMSC), Hasselt, Pelt, Belgium.
Abstract:
Multiple Sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system, causing increased vulnerability to infections and disability among young adults. Ever since the outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infections, there have been concerns among people with MS (PwMS) about the potential interactions between various disease-modifying therapies and COVID-19. The COVID-19 in MS Global Data Sharing Initiative (GDSI) was initiated in 2020 with the aim of addressing these concerns. This paper focuses on the anonymisation and publicly releasing of a GDSI sub-dataset, comprising data entered by PwMS and clinicians using a fast data entry tool. The dataset includes information on demographics, comorbidities and hospital stay and COVID-19 symptoms of PwMS. The dataset can be used to perform different statistical analyses to improve our understanding of COVID-19 in MS. Furthermore, this dataset can also be used within the context of educational activities to educate different stakeholders on the complex data science topics that were used within the GDSI.
Insights
This study addresses concerns about COVID-19 in people with Multiple Sclerosis (MS) by releasing a dataset. This data aids understanding of COVID-19 impacts and informs educational efforts on data science in MS research.
Area of Science:
- Neurology
- Infectious Diseases
- Data Science
Background:
- Multiple Sclerosis (MS) is an autoimmune disease increasing infection risk in young adults.
- Concerns exist regarding COVID-19 interactions with MS disease-modifying therapies.
- The COVID-19 in MS Global Data Sharing Initiative (GDSI) was established to address these concerns.
Purpose of the Study:
- To anonymize and release a sub-dataset from the GDSI.
- To provide data for statistical analysis on COVID-19 in MS patients.
- To support educational activities on data science within MS research.
Main Methods:
- Data anonymization techniques applied to GDSI sub-dataset.
- Public release of a dataset containing PwMS demographics, comorbidities, and COVID-19 information.
- Utilized a fast data entry tool for data collection.
Main Results:
- A comprehensive dataset on COVID-19 in people with MS (PwMS) is now publicly available.
- The dataset facilitates research into COVID-19's effects on PwMS.
- The data supports educational initiatives in data science for MS.
Conclusions:
- The released GDSI dataset is a valuable resource for understanding COVID-19 in MS.
- This initiative enhances research capabilities and data science education in the MS community.
- Publicly sharing data promotes transparency and collaborative research in neuro-immunology.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Bioavailability Study Design: Healthy Subjects Versus Patients
Cytomegalovirus Disease
Multiple Sclerosis l: Introduction

